Leonard L. Mazur
Known title: Chief Executive OfficerCIK: 0001463414
Leonard L. Mazur's purchase track record
Leonard L. Mazur has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 1/14/2022 | CNTN | $100K | -51.9% | -56.8% | -17.2% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| CTOR | ▲ Buy | Grant | 1,700,000 | $0 | 9/19/2025 | View on chart |
| CNTN | ▼ Sell | Other | 98,733 | $316K | 1/14/2022 | View on chart |
| CNTN | ▲ Buy | Open Market | 25,000 | $100K | 1/14/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 13, 2026
CTOR to Join October 2026 Investor Conferences
Citius Oncology announced it will take part in investor conferences scheduled for October 2026. The events give the company a platform to present its pipeline and business updates to potential investors. The stock is currently trading near its long‑term support level, which may be observed by attendees.
CTOR to Join October 2026 Investor Conferences. Citius Oncology announced it will take part in investor conferences scheduled for October 2026. The events give the company a platform to present its pipeline and business updates to potential investors. The stock is currently trading near its long‑term support level, which may be observed by attendees.